Correlation Between Eliem Therapeutics and Eton Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Eton Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Eton Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Eton Pharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Eton Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Eton Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Eton Pharmaceuticals.

Diversification Opportunities for Eliem Therapeutics and Eton Pharmaceuticals

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Eliem and Eton is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Eton Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eton Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Eton Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eton Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Eton Pharmaceuticals go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Eton Pharmaceuticals

Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 2.94 times less return on investment than Eton Pharmaceuticals. In addition to that, Eliem Therapeutics is 1.43 times more volatile than Eton Pharmaceuticals. It trades about 0.02 of its total potential returns per unit of risk. Eton Pharmaceuticals is currently generating about 0.09 per unit of volatility. If you would invest  364.00  in Eton Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  910.00  from holding Eton Pharmaceuticals or generate 250.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.75%
ValuesDaily Returns

Eliem Therapeutics  vs.  Eton Pharmaceuticals

 Performance 
       Timeline  
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Eton Pharmaceuticals 

Risk-Adjusted Performance

33 of 100

 
Weak
 
Strong
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eton Pharmaceuticals are ranked lower than 33 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Eton Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Eliem Therapeutics and Eton Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eliem Therapeutics and Eton Pharmaceuticals

The main advantage of trading using opposite Eliem Therapeutics and Eton Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Eton Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will offset losses from the drop in Eton Pharmaceuticals' long position.
The idea behind Eliem Therapeutics and Eton Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.